Global Cell and Gene Therapy Supply Chain and Logistics Supply, Demand and Key Producers, 2023-2029

Page: 129

Published Date: 12 May 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Cell and Gene Therapy Supply Chain and Logistics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Cell and Gene Therapy Supply Chain and Logistics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Supply Chain and Logistics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Supply Chain and Logistics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Supply Chain and Logistics total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Supply Chain and Logistics total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market By Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Clarkston Consulting and Hypertrust Patient Data Care, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Supply Chain and Logistics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and By Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell and Gene Therapy Supply Chain and Logistics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Supply Chain and Logistics Market, Segmentation by Type
    Ordering and Scheduling Services
    Sample Collection Services
    Logistics Services
    Post Treatment Follow-Up Services

Global Cell and Gene Therapy Supply Chain and Logistics Market, Segmentation By Application
    Biobank
    Cell Therapy Lab
    Hospital
    Research Institute

Companies Profiled:
    Be The Match BioTherapies
    Biocair
    Marken
    World Courier
    MAK-SYSTEM
    Cryoport
    Brooks Life Sciences
    Clarkston Consulting
    Hypertrust Patient Data Care
    Haemonetics
    MasterControl
    TraceLink
    SAVSU Technologies
    TrakCel
    Title21 Health Solutions
    sedApta Group
    Vineti
    Stafa Cellular Therapy
    Thermo Fisher Scientific
    McKesson
    BioLife Solutions

Key Questions Answered
1. How big is the global Cell and Gene Therapy Supply Chain and Logistics market?
2. What is the demand of the global Cell and Gene Therapy Supply Chain and Logistics market?
3. What is the year over year growth of the global Cell and Gene Therapy Supply Chain and Logistics market?
4. What is the total value of the global Cell and Gene Therapy Supply Chain and Logistics market?
5. Who are the major players in the global Cell and Gene Therapy Supply Chain and Logistics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Supply Chain and Logistics Introduction
    1.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cell and Gene Therapy Supply Chain and Logistics Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.3 China Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.5 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.6 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.7 ASEAN Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
        1.3.8 India Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Supply Chain and Logistics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023)
        2.2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.4 China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.5 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.6 Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.7 South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.8 ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
    2.9 India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)

3 World Cell and Gene Therapy Supply Chain and Logistics Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics in 2022
    3.3 Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
        3.4.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
        4.3.1 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
    4.4 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue and Market Share, 2018-2023
        4.4.1 China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
    4.5 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Ordering and Scheduling Services
        5.2.2 Sample Collection Services
        5.2.3 Logistics Services
        5.2.4 Post Treatment Follow-Up Services
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023)
        5.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029)
        5.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)

6 Market Analysis By Application
    6.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview By Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction By Application
        6.2.1 Biobank
        6.2.2 Cell Therapy Lab
        6.2.3 Hospital
        6.2.4 Research Institute
        6.2.5 Research Institute
    6.3 Market Segment By Application
        6.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023)
        6.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029)
        6.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2029)

7 Company Profiles
    7.1 Be The Match BioTherapies
        7.1.1 Be The Match BioTherapies Details
        7.1.2 Be The Match BioTherapies Major Business
        7.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Be The Match BioTherapies Recent Developments/Updates
        7.1.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
    7.2 Biocair
        7.2.1 Biocair Details
        7.2.2 Biocair Major Business
        7.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Biocair Recent Developments/Updates
        7.2.6 Biocair Competitive Strengths & Weaknesses
    7.3 Marken
        7.3.1 Marken Details
        7.3.2 Marken Major Business
        7.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Marken Recent Developments/Updates
        7.3.6 Marken Competitive Strengths & Weaknesses
    7.4 World Courier
        7.4.1 World Courier Details
        7.4.2 World Courier Major Business
        7.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 World Courier Recent Developments/Updates
        7.4.6 World Courier Competitive Strengths & Weaknesses
    7.5 MAK-SYSTEM
        7.5.1 MAK-SYSTEM Details
        7.5.2 MAK-SYSTEM Major Business
        7.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 MAK-SYSTEM Recent Developments/Updates
        7.5.6 MAK-SYSTEM Competitive Strengths & Weaknesses
    7.6 Cryoport
        7.6.1 Cryoport Details
        7.6.2 Cryoport Major Business
        7.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Cryoport Recent Developments/Updates
        7.6.6 Cryoport Competitive Strengths & Weaknesses
    7.7 Brooks Life Sciences
        7.7.1 Brooks Life Sciences Details
        7.7.2 Brooks Life Sciences Major Business
        7.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Brooks Life Sciences Recent Developments/Updates
        7.7.6 Brooks Life Sciences Competitive Strengths & Weaknesses
    7.8 Clarkston Consulting
        7.8.1 Clarkston Consulting Details
        7.8.2 Clarkston Consulting Major Business
        7.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Clarkston Consulting Recent Developments/Updates
        7.8.6 Clarkston Consulting Competitive Strengths & Weaknesses
    7.9 Hypertrust Patient Data Care
        7.9.1 Hypertrust Patient Data Care Details
        7.9.2 Hypertrust Patient Data Care Major Business
        7.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Hypertrust Patient Data Care Recent Developments/Updates
        7.9.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
    7.10 Haemonetics
        7.10.1 Haemonetics Details
        7.10.2 Haemonetics Major Business
        7.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Haemonetics Recent Developments/Updates
        7.10.6 Haemonetics Competitive Strengths & Weaknesses
    7.11 MasterControl
        7.11.1 MasterControl Details
        7.11.2 MasterControl Major Business
        7.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 MasterControl Recent Developments/Updates
        7.11.6 MasterControl Competitive Strengths & Weaknesses
    7.12 TraceLink
        7.12.1 TraceLink Details
        7.12.2 TraceLink Major Business
        7.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 TraceLink Recent Developments/Updates
        7.12.6 TraceLink Competitive Strengths & Weaknesses
    7.13 SAVSU Technologies
        7.13.1 SAVSU Technologies Details
        7.13.2 SAVSU Technologies Major Business
        7.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 SAVSU Technologies Recent Developments/Updates
        7.13.6 SAVSU Technologies Competitive Strengths & Weaknesses
    7.14 TrakCel
        7.14.1 TrakCel Details
        7.14.2 TrakCel Major Business
        7.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 TrakCel Recent Developments/Updates
        7.14.6 TrakCel Competitive Strengths & Weaknesses
    7.15 Title21 Health Solutions
        7.15.1 Title21 Health Solutions Details
        7.15.2 Title21 Health Solutions Major Business
        7.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Title21 Health Solutions Recent Developments/Updates
        7.15.6 Title21 Health Solutions Competitive Strengths & Weaknesses
    7.16 sedApta Group
        7.16.1 sedApta Group Details
        7.16.2 sedApta Group Major Business
        7.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 sedApta Group Recent Developments/Updates
        7.16.6 sedApta Group Competitive Strengths & Weaknesses
    7.17 Vineti
        7.17.1 Vineti Details
        7.17.2 Vineti Major Business
        7.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Vineti Recent Developments/Updates
        7.17.6 Vineti Competitive Strengths & Weaknesses
    7.18 Stafa Cellular Therapy
        7.18.1 Stafa Cellular Therapy Details
        7.18.2 Stafa Cellular Therapy Major Business
        7.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Stafa Cellular Therapy Recent Developments/Updates
        7.18.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
    7.19 Thermo Fisher Scientific
        7.19.1 Thermo Fisher Scientific Details
        7.19.2 Thermo Fisher Scientific Major Business
        7.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Thermo Fisher Scientific Recent Developments/Updates
        7.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.20 McKesson
        7.20.1 McKesson Details
        7.20.2 McKesson Major Business
        7.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 McKesson Recent Developments/Updates
        7.20.6 McKesson Competitive Strengths & Weaknesses
    7.21 BioLife Solutions
        7.21.1 BioLife Solutions Details
        7.21.2 BioLife Solutions Major Business
        7.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
        7.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
        7.21.5 BioLife Solutions Recent Developments/Updates
        7.21.6 BioLife Solutions Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
    8.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
    8.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
    8.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Supply Chain and Logistics Players in 2022
    Table 12. World Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Player
    Table 15. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Supply Chain and Logistics Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
    Table 23. China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
    Table 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023) & (USD Million)
    Table 34. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029) & (USD Million)
    Table 35. Be The Match BioTherapies Basic Information, Area Served and Competitors
    Table 36. Be The Match BioTherapies Major Business
    Table 37. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 38. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Be The Match BioTherapies Recent Developments/Updates
    Table 40. Be The Match BioTherapies Competitive Strengths & Weaknesses
    Table 41. Biocair Basic Information, Area Served and Competitors
    Table 42. Biocair Major Business
    Table 43. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 44. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Biocair Recent Developments/Updates
    Table 46. Biocair Competitive Strengths & Weaknesses
    Table 47. Marken Basic Information, Area Served and Competitors
    Table 48. Marken Major Business
    Table 49. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 50. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Marken Recent Developments/Updates
    Table 52. Marken Competitive Strengths & Weaknesses
    Table 53. World Courier Basic Information, Area Served and Competitors
    Table 54. World Courier Major Business
    Table 55. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 56. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. World Courier Recent Developments/Updates
    Table 58. World Courier Competitive Strengths & Weaknesses
    Table 59. MAK-SYSTEM Basic Information, Area Served and Competitors
    Table 60. MAK-SYSTEM Major Business
    Table 61. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 62. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. MAK-SYSTEM Recent Developments/Updates
    Table 64. MAK-SYSTEM Competitive Strengths & Weaknesses
    Table 65. Cryoport Basic Information, Area Served and Competitors
    Table 66. Cryoport Major Business
    Table 67. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 68. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Cryoport Recent Developments/Updates
    Table 70. Cryoport Competitive Strengths & Weaknesses
    Table 71. Brooks Life Sciences Basic Information, Area Served and Competitors
    Table 72. Brooks Life Sciences Major Business
    Table 73. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 74. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Brooks Life Sciences Recent Developments/Updates
    Table 76. Brooks Life Sciences Competitive Strengths & Weaknesses
    Table 77. Clarkston Consulting Basic Information, Area Served and Competitors
    Table 78. Clarkston Consulting Major Business
    Table 79. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 80. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Clarkston Consulting Recent Developments/Updates
    Table 82. Clarkston Consulting Competitive Strengths & Weaknesses
    Table 83. Hypertrust Patient Data Care Basic Information, Area Served and Competitors
    Table 84. Hypertrust Patient Data Care Major Business
    Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Hypertrust Patient Data Care Recent Developments/Updates
    Table 88. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
    Table 89. Haemonetics Basic Information, Area Served and Competitors
    Table 90. Haemonetics Major Business
    Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 92. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Haemonetics Recent Developments/Updates
    Table 94. Haemonetics Competitive Strengths & Weaknesses
    Table 95. MasterControl Basic Information, Area Served and Competitors
    Table 96. MasterControl Major Business
    Table 97. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 98. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. MasterControl Recent Developments/Updates
    Table 100. MasterControl Competitive Strengths & Weaknesses
    Table 101. TraceLink Basic Information, Area Served and Competitors
    Table 102. TraceLink Major Business
    Table 103. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 104. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. TraceLink Recent Developments/Updates
    Table 106. TraceLink Competitive Strengths & Weaknesses
    Table 107. SAVSU Technologies Basic Information, Area Served and Competitors
    Table 108. SAVSU Technologies Major Business
    Table 109. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 110. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. SAVSU Technologies Recent Developments/Updates
    Table 112. SAVSU Technologies Competitive Strengths & Weaknesses
    Table 113. TrakCel Basic Information, Area Served and Competitors
    Table 114. TrakCel Major Business
    Table 115. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 116. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. TrakCel Recent Developments/Updates
    Table 118. TrakCel Competitive Strengths & Weaknesses
    Table 119. Title21 Health Solutions Basic Information, Area Served and Competitors
    Table 120. Title21 Health Solutions Major Business
    Table 121. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 122. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Title21 Health Solutions Recent Developments/Updates
    Table 124. Title21 Health Solutions Competitive Strengths & Weaknesses
    Table 125. sedApta Group Basic Information, Area Served and Competitors
    Table 126. sedApta Group Major Business
    Table 127. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 128. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. sedApta Group Recent Developments/Updates
    Table 130. sedApta Group Competitive Strengths & Weaknesses
    Table 131. Vineti Basic Information, Area Served and Competitors
    Table 132. Vineti Major Business
    Table 133. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 134. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Vineti Recent Developments/Updates
    Table 136. Vineti Competitive Strengths & Weaknesses
    Table 137. Stafa Cellular Therapy Basic Information, Area Served and Competitors
    Table 138. Stafa Cellular Therapy Major Business
    Table 139. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 140. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Stafa Cellular Therapy Recent Developments/Updates
    Table 142. Stafa Cellular Therapy Competitive Strengths & Weaknesses
    Table 143. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 144. Thermo Fisher Scientific Major Business
    Table 145. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 146. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Thermo Fisher Scientific Recent Developments/Updates
    Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 149. McKesson Basic Information, Area Served and Competitors
    Table 150. McKesson Major Business
    Table 151. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 152. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 153. McKesson Recent Developments/Updates
    Table 154. BioLife Solutions Basic Information, Area Served and Competitors
    Table 155. BioLife Solutions Major Business
    Table 156. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
    Table 157. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 158. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
    Table 159. Cell and Gene Therapy Supply Chain and Logistics Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
    Figure 2. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
    Figure 13. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
    Figure 27. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type in 2022
    Figure 31. Ordering and Scheduling Services
    Figure 32. Sample Collection Services
    Figure 33. Logistics Services
    Figure 34. Post Treatment Follow-Up Services
    Figure 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)
    Figure 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share By Application in 2022
    Figure 38. Biobank
    Figure 39. Cell Therapy Lab
    Figure 40. Hospital
    Figure 41. Research Institute
    Figure 42. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions

Related Reports

Global Cell and Gene Therapy Supply Chain and Logistics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Cell and Gene Therapy Supply Chain and Logistics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 12 May 2023

date Service & Software

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 29 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Cell and Gene Therapy Supply Chain and Logistics Supply, Demand and Key Producers, 2024-2030

Global Cell and Gene Therapy Supply Chain and Logistics Supply, Demand and Key Producers, 2024-2030

date 29 Jan 2024

date Service & Software

The global Cell and Gene Therapy Supply Chain and Logistics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Cell and Gene Therapy Supply Chain and Logistics

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>